Related Experiment Video
Updated: Jun 17, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Amphiregulin Downregulates E-cadherin Expression by Activating YAP/Egr-1/Slug Signaling in SKOV3 Human Ovarian Cancer
Qiongqiong Jia1,2, Hailong Wang1, Beibei Bi1
1Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
Amphiregulin (AREG) stimulates human epithelial ovarian cancer (EOC) cell invasion by downregulating E-cadherin expression. YAP is a transcriptional cofactor that has been shown to regulate tumorigenesis. This study aimed to examine whether AREG activates YAP in EOC cells and explore the roles of YAP in AREG-induced downregulation of E-cadherin and cell invasion. Analysis of the Cancer Genome Atlas (TCGA) showed that upregulation of AREG and EGFR were associated with poor survival in human EOC. Treatment of SKOV3 human EOC cells with AREG induced the activation of YAP. In addition, AREG downregulated E-cadherin, upregulated Egr-1 and Slug, and stimulated cell invasion. Using gain- and loss-of-function approaches, we showed that YAP was required for the AREG-upregulated Egr-1 and Slug expression. Furthermore, YAP was also involved in AREG-induced downregulation of E-cadherin and cell invasion. This study provides evidence that AREG stimulates human EOC cell invasion by downregulating E-cadherin expression through the YAP/Egr-1/Slug signaling.
Insights
Amphiregulin (AREG) drives ovarian cancer invasion by reducing E-cadherin via YAP activation. This pathway, involving Egr-1 and Slug, highlights YAP as a therapeutic target for epithelial ovarian cancer (EOC).
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Amphiregulin (AREG) is implicated in epithelial ovarian cancer (EOC) progression.
- Yeast-retroviral protein-associated (YAP) is a transcriptional cofactor involved in tumorigenesis.
- AREG's role in YAP activation and its downstream effects in EOC remain unclear.
Purpose of the Study:
- To investigate if AREG activates YAP in EOC cells.
- To explore YAP's role in AREG-induced E-cadherin downregulation and cell invasion.
- To elucidate the signaling pathway linking AREG, YAP, and EOC cell invasion.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) data for AREG and EGFR correlations with EOC survival.
- Treatment of SKOV3 EOC cells with AREG to assess YAP activation, E-cadherin, Egr-1, and Slug expression.
- Gain- and loss-of-function experiments to determine YAP's necessity in AREG-mediated effects.
Main Results:
- TCGA analysis revealed AREG and EGFR upregulation correlates with poor EOC survival.
- AREG treatment activated YAP, downregulated E-cadherin, upregulated Egr-1 and Slug, and increased EOC cell invasion.
- YAP was essential for AREG-induced Egr-1 and Slug expression, E-cadherin downregulation, and enhanced cell invasion.
Conclusions:
- AREG activates YAP in human EOC cells.
- AREG stimulates EOC cell invasion by downregulating E-cadherin.
- The YAP/Egr-1/Slug signaling pathway mediates AREG-induced EOC cell invasion and E-cadherin suppression.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Regulation of Angiogenesis and Blood Supply
Mitogens and the Cell Cycle

